Market Research Futurer

  Market Overview A CAGR of 7.8 per cent is expected for the forecast period between 2022 and 2027, bringing the total global  cosmetic surgery market Size  to USD 21.97 billion. Plastic surgery is a subcategory of surgery for those who want to enhance their appearance via cosmetic procedures. There is a growing demand for cosmetic surgery due to improved safety margins, overweight, mishaps, and the growth of cosmetic surgery facilities. Cosmetic surgery has a growing safety margin and a rising prevalence of cosmetic surgery facilities, among other things, all of which impact people's health. Innovative materials, like silicone implants, are one example of a technological component. The global cosmetic surgery market is being driven by increased income levels, decreased plastic surgery prices, etc. The cosmetic surgery business is predicted to grow at a much slower rate in 2020 because of the COVID-19 epidemic. A steady rise is expected to continue during this forecast pe...

  Anti-Viral Drugs Market - Highlights Anti-viral drugs are used to treat viral infections and are the only agents acting against viruses as either other drugs are ineffective or too toxic. The market segment of  anti-viral drugs market Size  is driven by factors such as rise in healthcare expenditure, growing research and development investment, emergence of virus life-threatening diseases like bird flu, strong development pipeline and increasing incidence rates of viral infections particularly HIV. WHO has estimated that in 2015 about 36.7 million people are suffering from HIV/AIDS with 1.1 million deaths occurring due to AIDS-related illness the emergence of donor funding in the treatment of the disease has also increased the demands of anti-viral drug market. Strong research pipeline coupled with rise in research and development investment antiviral medicine will be the market driver of the future. The constraints on the market include side effects associated with tre...

  Market Scope Market Research Future (MRFR) assessed the global LASIK eye surgerys market 2021 in the analysis period till 2027. As per MRFR study, the global  LASIK eye surgerys market Size  is expected to expand at 6.5% CAGR during the evaluation period (from 2022 to 2027). By 2027, the global LASIK eye surgerys market is expected to garner high revenue. Market Drivers and Restraints The rise in demand for Laser-Assisted In Situ Keratomileusis (LASIK) surgeries to treat myopia, astigmatism, and hyperopia among other visual impairments due to their high precision is expected to prompt the market expansion. People are inclined towards improving their aesthetic appeal and often want to eliminate the uses of specks. The increasing popularity of corrective eye surgery owing to technologically advanced instruments can add to the market expansion that can favor the LASIK eye surgeries market in the review period. Other causes, such as, availability of expertise and the presen...

  Market Highlights Intraoral cameras is gaining popularity from last few years because of its advantages in the field of dentistry. USB camera are most widely used cameras. Growing emphasis on dental health and ever increasing use of dental cosmetics favor the demand of intraoral camera across the globe. Number of dental clinics are increasing tremendously in developed and developing countries leads to an increase in the demand of dental equipments. Global  Intraoral cameras market Size  was about is expected to reach USD 2450 million by 2027 at a CAGR of 9.5% during forecast period 2022 to 2027. Taste the market data and market information presented through more than 45 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Intraoral cameras market Research Report –Global Forecast to 2027.” Intraoral cameras Market Players: Key players in intraoral cameras market are: Danahe...

  Market Highlights According to MRFR analysis, the Global Carrier Screening Market is expected to register a CAGR of 16.8% during the forecast period of 2019 to 2025 and is anticipated to reach USD 4,200 Million by 2025. The growth of the global carrier screening market is driven by various factors, such as the increasing launch of carrier screening products and growing numbers of players involved in the development of new carrier screening technologies. Some of the key companies operating in this market are Eurofins Scientific, Invitae Corporation, Illumina Inc, Luminex Corporation and others. In addition, the rising awareness program about genetic disorders supports the  Carrier Screening Market size  during the forecasted period. However, the lack of skilled professionals and accuracy issues of carrier screening products may hamper market growth. Key Players Some of the key players in the Global Carrier Screening Market are Eurofins Scientific (Luxembourg), Invitae Co...

  Market Forecast Registering a CAGR of 8.6%, the Global  Cell Lysis & Disruption Market size  is expected to reach USD 5.7 Billion in by 2030.  The expanding biotechnology and biopharmaceutical sector are driving the growth of this market. For instance, firms in the U.S. firms perform extensive R&D in pharmaceuticals which is approximately USD 75 billion. The market is dominated by numerous established players. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in June 2018, Thermo Fisher Scientific acquired Gatan, Inc. from Roper Technologies for approximately USD 925 million. Market Influencers The rising focus on personalized medicine would directly drive the growth of the global cell lysis & disruption market. Strategic initiatives, mergers & acquisitions, partnerships, agreements, product launches, government approvals, and expansion of manufacturing facilities by maj...

  Stem Cell Manufacturing Market - Highlights The Stem Cell Manufacturing Industry is expected to have accounted for the market value of USD 10.8 billion in 2022 and is projected to grow at a Stem Cell Manufacturing Market CAGR of 6.6% over the assessment period. Stem cell manufacturing is a process in which cells from the bone marrow or peripheral blood cells are isolated and cultured in a culture dish containing nutrient media. Rising stem cell related transplants, increasing number of clinical trials for stem cell therapies and growing stem cell research is anticipated to boost the growth of the market during the assessment period. According to a report published by Lozier Institute in November 2022, there are nearly 3,500 ongoing or completed clinical trials (in patients) using adult stem cells, as listed in the National Institutes of Health/FDA-approved database. On the other hand, high costs associated with stem cell research and stringent govern...

  Market Highlights The global  hemostasis and tissue sealing agents market size  is projected to grow at a CAGR of 8.6% over the forecast period. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation. Hemostasis and tissue sealing agents products are used in external surgical processes for reducing bleeding. For example, they are used in neurosurgical procedures, cardiac surgery, bariatric surgery, leg surgery, cesarean and orthopedic surgery. Hemostasis and tissue sealing agents products, are frequently used to reduce complexity and reduce recovery time after surgery. T...

  Market Scope Market Research Future (MRFR) studied the global  closed system drug transfer device (CSTD) market size  for the review tenure till 2030. As per MRFR analysis, the closed system drug transfer device market is expected to rise at 19.10% CAGR over the assessment tenure till. By 2030, the closed system drug transfer device (CSTD) market can garner decent revenue. Drivers and Restrains Impacting Closed System Drug Transfer Device (CSTD) Market The growth of the  closed System Drug Transfer Device Market  can be attributed to the increasing prevalence of cancer across the globe. CSTDs are used for protecting hospital staff from exposure to hazardous drugs, thus ensuring their safety. Moreover, safety guidelines provided by regulatory authorities for safe handling practices at clinics and hospitals is predicted to prompt the rise of closed system drug transfer device (CSTD) market. Some developing economies offer several opportunities for the CSTD marke...

  Market Analysis The global  immunoprecipitation market Size  is predicted to touch USD 562 million at a 5.2% CAGR over the forecast period (2022-2030), states the new Market Research Future (MRFR) report. Immunoprecipitation (IP), simply put, is a technique to precipitate a protein antigen out of a solution utilizing an antibody which specifically binds to that specific protein. The process can be used for isolating and concentrating a specific protein from a sample having thousands of various proteins. The IP technique help researchers in identifying the proteins activation status, determining protein modifications that are post-translational, measuring a given protein’s molecular weight, and capturing protein-binding molecules in both the study of protein-nucleic and protein-protein interactions. Various factors are propelling the immunoprecipitation market growth. These factors, as per the new MRFR report, include increasing number of research activities in life scie...

  Retinal Implants Market Overview: Retinal implants have cropped up as breakthrough therapy in the treatment of visual impairment. The global  retinal implants market size  is advancing at a rapid pace and is projected to reach a significant valuation in the forthcoming years, reveals Market Research Future (MRFR) in a recently published research report. The widespread prevalence of retinal disorders such as age-related macular degeneration and retinitis pigmentosa has generated considerable demand for retinal implants. Retinal implants have demonstrated significant restoration of vision in cases which were previously far off impossible to achieve. Growing popularity of minimally invasive surgical techniques is a crucial driver of the global retinal implants market. Retinal implants do not require much invasion and can be implanted with minimal incision which makes patients opt for them. The growth in the global retinal implants market can also be attributed to the rise ...

  Overview: Providing detailed care to patients suffering from damaged vessels during an operation is of utmost importance as this can trigger substantial blood loss. Hemostasis is the formation of blood clots near the site of the injury. Surgical instruments that help in controlling blood loss by forming temporary clots are known as hemostats. It is also known as arterial forceps, hemostatic clamp, and pean after Jules-Émile Péan. The process is often implemented at an early stage of incision to close blood vessels from ligation. Increasing number of surgical procedures, innovation, rising cases of wounds & accidents, and demand for blood loss management are factors that can boost the global  Hemostats Market Size . All these are getting amply backed by technological advancements. Factors such as these will take the hemostats market forward in the coming years. Competitive Landscape: The global  hemostats market  depends on strategy-making policies of several co...

  Market Highlights According to MRFR analysis, Biosimulation Market size  is expected to register a CAGR of 15.9% during the forecast period of 2022 to 2030 and is likely to be valued at USD 4.4 Billion by 2030.  Biosimulation is a tool used for the prediction of the outcomes of existing clinical trials associated with innovation and new drug development. The growth of the Global biosimulation Market is determined by numerous factors such as the growing adoption of biosimulation software by regulatory bodies, increasing healthcare expenditure, increasing use of pharmacokinetic & pharmacodynamic modelling in pre-clinical development and rising need to reduce the drug development costs. However, lack of standardization in biosimulation methodology and lack of trained professionals for monitoring biosimulation software are likely to hamper the growth of the global biosimulation market during the forecast period.  Several market players currently dominate the Global...

  Market Overview AR & VR in Healthcare Market Size  is expected to grow at a CAGR of 27.30% during the forecast period. Virtual reality technology benefits both doctors and patients since it allows patients to virtually visit doctors, which is very convenient. This has propelled the growth of the VR market in the healthcare business to a large extent. VR technology is ahead of Augmented Reality due to its expanded capabilities. Virtual reality allows users to immerse themselves in another environment and interact with it in real-time. In contrast, AR produces a visual environment around you but does not allow you to interact with it. New start-ups keen to capitalize on this extensively utilized technology are among the factors fueling the growth of AR & VR in the Healthcare Market. By combining AR and VR technology into new applications and adding new features to existing products, these start-ups are growing their AR and VR application portfolios. Product pricing has...

  CAR T Cell Therapy Market-Overview Chimeric Antigen Receptor (CAR)-T is a revolutionary treatment that involves reengineering the patient's white blood cells (WBCs) to assist in the fight against cancerous cells by identifying them. The industry is taking steps to address various issues to foster the adoption of  CAR-T cell therapy maeket size . Several CAR-T players have begun to impregnate T cells with CARs using efficient gene-transfer techniques to treat several conditions. As per MRFR, the market is estimated to utilize a CAGR of 48.96% and reach USD 10,415.61 million by the end of the period in 2027. Over the forecast period, soaring cancer incidences around the world, together with persistent technical advancements for dependable and effective cancer treatment, are likely to support the progress of the worldwide CAR-T cell therapy market. Key Players: The important companies in the CAR T cell therapy market are Intellia Therapeutics (US), Merck KGaA (Germany), Servier...